Published in Psychopharmacology (Berl) on May 10, 2007
Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacol Rev (2013) 1.16
Emotional valence and context of social influences on drug abuse-related behavior in animal models of social stress and prosocial interaction. Psychopharmacology (Berl) (2012) 0.97
Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine. Mol Cell Neurosci (2011) 0.80
A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning. Sci Rep (2015) 0.76
Maternal Separation Impairs Cocaine-Induced Behavioural Sensitization in Adolescent Mice. PLoS One (2016) 0.75
Dopamine, learning and motivation. Nat Rev Neurosci (2004) 11.97
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (1990) 6.18
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci (1996) 1.78
Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev (2003) 1.78
Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci (2003) 1.57
Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male Wistar rats. Neuroscience (2003) 1.21
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther (2000) 1.20
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther (1993) 1.18
Endogenous opioids and reward. Eur J Pharmacol (2000) 1.03
Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor. Eur J Pharmacol (2000) 1.02
Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci (1998) 0.97
Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci (1997) 0.96
D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev (2001) 0.94
Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res Mol Brain Res (2003) 0.94
A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci (1984) 0.93
The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. Eur J Pharmacol (2001) 0.89
D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. J Neurochem (2002) 0.86
Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood. J Neurosci (2005) 0.84
Neonatal isolation enhances maintenance but not reinstatement of cocaine self-administration in adult male rats. Psychopharmacology (Berl) (2004) 0.83
Brief early handling increases morphine dependence in adult rats. Behav Brain Res (2006) 0.82
Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology (Berl) (2005) 0.82
The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol (1995) 0.81
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci (2002) 2.71
Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet (2008) 1.65
A tale of two oxidation states: bacterial colonization of arsenic-rich environments. PLoS Genet (2007) 1.59
The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci (2008) 1.57
Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat Neurosci (2010) 1.52
Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. Eur J Neurosci (2013) 1.49
Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci (2007) 1.48
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci (2012) 1.43
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology (2006) 1.30
VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci (2010) 1.29
Structure, function, and evolution of the Thiomonas spp. genome. PLoS Genet (2010) 1.27
Pichia sorbitophila, an Interspecies Yeast Hybrid, Reveals Early Steps of Genome Resolution After Polyploidization. G3 (Bethesda) (2012) 1.12
Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci (2004) 1.11
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci (2004) 1.06
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem (2008) 1.05
Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation (2014) 1.04
Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology (2011) 1.03
Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology (2005) 1.01
Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J Neurochem (2008) 1.00
Endogenous morphine-like compound immunoreactivity increases in parkinsonism. Brain (2011) 1.00
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry (2005) 1.00
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology (2007) 0.98
Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology (2005) 0.98
Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging (2006) 0.97
The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances. J Neurochem (2012) 0.97
Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus. PLoS One (2008) 0.96
The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network. J Neurochem (2010) 0.96
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging (2007) 0.96
Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem Neurosci (2012) 0.95
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Neuropharmacology (2007) 0.91
Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. Am J Med Genet B Neuropsychiatr Genet (2007) 0.91
The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci (2005) 0.91
Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. J Neurochem (2006) 0.90
Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Res Dev Brain Res (2003) 0.90
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol (2010) 0.90
Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacology (2007) 0.89
Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.88
[Genetics of autism: from genome scans to candidate genes]. Med Sci (Paris) (2003) 0.87
Maternal deprivation specifically enhances vulnerability to opiate dependence. Behav Pharmacol (2006) 0.86
Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci (2005) 0.86
Lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study. J Comp Neurol (2003) 0.86
Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behav Brain Funct (2008) 0.85
Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood. J Neurosci (2005) 0.84
Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice. Neuropharmacology (2007) 0.84
Maternal deprivation induces depressive-like behaviours only in female rats. Behav Brain Res (2010) 0.83
Doublecortin knockout mice show normal hippocampal-dependent memory despite CA3 lamination defects. PLoS One (2013) 0.83
Brief early handling increases morphine dependence in adult rats. Behav Brain Res (2006) 0.82
Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology (Berl) (2005) 0.82
Chronic valproate normalizes behavior in mice overexpressing calcineurin. Eur J Pharmacol (2007) 0.81
Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801. Neuropharmacology (2011) 0.81
Insights into the life cycle of yeasts from the CTG clade revealed by the analysis of the Millerozyma (Pichia) farinosa species complex. PLoS One (2012) 0.80
Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization. Neuropsychopharmacology (2005) 0.80
Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorg Med Chem (2010) 0.80
Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex. Neurobiol Learn Mem (2012) 0.80
Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. J Neurochem (2012) 0.79
Inhibition of dopamine transporter activity impairs synaptic depression in rat prefrontal cortex through over-stimulation of D1 receptors. Cereb Cortex (2012) 0.79
Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes. Eur J Pharmacol (2010) 0.79
Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology (Berl) (2009) 0.78
New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.78
Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation. Addict Biol (2013) 0.78
New perspectives in hemiascomycetous yeast taxonomy. C R Biol (2011) 0.78
Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology (2009) 0.77
Leucine and citrulline modulate muscle function in malnourished aged rats. Amino Acids (2011) 0.77
Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat. Neuropharmacology (2012) 0.77
Genetic markers in psychiatric genetics. Methods Mol Med (2003) 0.77
The entorhinal cortex-nucleus accumbens pathway and latent inhibition: a behavioral and neurochemical study in rats. Behav Neurosci (2002) 0.77
The dopamine D1 receptor agonist SKF 38393 improves temporal order memory performance in maternally deprived rats. Neurobiol Learn Mem (2013) 0.76
Behavioral responses to ingestion of different sources of fat. Involvement of serotonin? Behav Brain Res (2002) 0.76
Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways. Neuropharmacology (2007) 0.75
Early stress leads to effects on estrous cycle and differential responses to stress. Physiol Behav (2010) 0.75
The CCK(2) agonist BC-264 decreases predatory fear freezing at high but not low dosages in PVG hooded rats during initial exposure to a cat. Peptides (2008) 0.75